Tuesday, 14 July 2026 06:15 PM
Class Action
NEW YORK CITY, NY / ACCESS Newswire / July 14, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into AstraZeneca PLC ("AstraZeneca PLC") (NYSE:AZN) concerning potential violations of the federal securities laws.
AstraZeneca PLC faces a securities investigation after shares fell more than 8.3% in early trading on July 9, 2026.
Wainua, a gene-silencing drug for transthyretin-mediated amyloid cardiomyopathy, had been positioned as a key value driver toward AstraZeneca's stated "$80 billion 2030 ambition." The Company referred to the trial as the "largest trial in this population" with the "potential to address key questions" unanswered in the community.
On July 9, 2026, AstraZeneca reported that the trail had failed, noting that "adding Wainua did not provide a statistically significant benefit on the composite outcome of CV mortality and recurrent CV events."
If you suffered a loss on your AstraZeneca PLC securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171
SOURCE: Levi & Korsinsky, LLP